280 related articles for article (PubMed ID: 29056713)
1. Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.
Varshney J; Scott MC; Largaespada DA; Subramanian S
Vet Sci; 2016 Jan; 3(1):. PubMed ID: 29056713
[TBL] [Abstract][Full Text] [Related]
2. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
3. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
4. MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects.
Leonardi L; Scotlandi K; Pettinari I; Benassi MS; Porcellato I; Pazzaglia L
Cells; 2021 Feb; 10(2):. PubMed ID: 33670554
[TBL] [Abstract][Full Text] [Related]
5. Low level amplification of c-sis and c-myc in a spontaneous osteosarcoma model.
Kochevar DT; Kochevar J; Garrett L
Cancer Lett; 1990 Sep; 53(2-3):213-22. PubMed ID: 2208081
[TBL] [Abstract][Full Text] [Related]
6. A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations.
Angstadt AY; Thayanithy V; Subramanian S; Modiano JF; Breen M
Cancer Genet; 2012 Nov; 205(11):572-87. PubMed ID: 23137772
[TBL] [Abstract][Full Text] [Related]
7. Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progression.
Paoloni M; Davis S; Lana S; Withrow S; Sangiorgi L; Picci P; Hewitt S; Triche T; Meltzer P; Khanna C
BMC Genomics; 2009 Dec; 10():625. PubMed ID: 20028558
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer and T Cell Infiltration in Canine Osteosarcoma: Clinical Implications and Translational Relevance.
Razmara AM; Judge SJ; Gingrich AA; Cruz SM; Culp WTN; Kent MS; Rebhun RB; Canter RJ
Front Vet Sci; 2021; 8():771737. PubMed ID: 34869744
[TBL] [Abstract][Full Text] [Related]
9. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
[TBL] [Abstract][Full Text] [Related]
10. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
11. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma.
De Maria R; Miretti S; Iussich S; Olivero M; Morello E; Bertotti A; Christensen JG; Biolatti B; Levine RA; Buracco P; Di Renzo MF
J Pathol; 2009 Jul; 218(3):399-408. PubMed ID: 19402129
[TBL] [Abstract][Full Text] [Related]
12. Improving Osteosarcoma Treatment: Comparative Oncology in Action.
Tarone L; Mareschi K; Tirtei E; Giacobino D; Camerino M; Buracco P; Morello E; Cavallo F; Riccardo F
Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556464
[TBL] [Abstract][Full Text] [Related]
13. Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.
Fan TM; Roberts RD; Lizardo MM
Front Oncol; 2020; 10():13. PubMed ID: 32082995
[TBL] [Abstract][Full Text] [Related]
14. Recent and current clinical trials in canine appendicular osteosarcoma.
Poon AC; Matsuyama A; Mutsaers AJ
Can Vet J; 2020 Mar; 61(3):301-308. PubMed ID: 32165755
[TBL] [Abstract][Full Text] [Related]
15. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
16. MET oncogene aberrant expression in canine osteosarcoma.
Ferracini R; Angelini P; Cagliero E; Linari A; Martano M; Wunder J; Buracco P
J Orthop Res; 2000 Mar; 18(2):253-6. PubMed ID: 10815826
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of genome-wide DNA methylation identifies patterns that associate with conserved transcriptional programs in osteosarcoma.
Mills LJ; Scott MC; Shah P; Cunanan AR; Deshpande A; Auch B; Curtin B; Beckman KB; Spector LG; Sarver AL; Subramanian S; Richmond TA; Modiano JF
Bone; 2022 May; 158():115716. PubMed ID: 33127576
[TBL] [Abstract][Full Text] [Related]
18. Genomic Complexity of Osteosarcoma and Its Implication for Preclinical and Clinical Targeted Therapies.
Schott C; Shah AT; Sweet-Cordero EA
Adv Exp Med Biol; 2020; 1258():1-19. PubMed ID: 32767231
[TBL] [Abstract][Full Text] [Related]
19. Integration of genomic, transcriptomic and functional profiles of aggressive osteosarcomas across multiple species.
Davis LE; Jeng S; Svalina MN; Huang E; Pittsenbarger J; Cantor EL; Berlow N; Seguin B; Mansoor A; McWeeney SK; Keller C
Oncotarget; 2017 Sep; 8(44):76241-76256. PubMed ID: 29100308
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
